Leicester Research Archive

Leicester Research Archive >
College of Medicine, Biological Sciences and Psychology >
Infection, Immunity and Inflammation, Department of >
Published Articles, Dept. of Infection, Immunity and Inflammation >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/27021

Title: CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathies.
Authors: Baines, RJ
Chana, RS
Hall, M
Febbraio, M
Kennedy, D
Brunskill, NJ
Issue Date: Oct-2012
Citation: AM J PHYSIOL RENAL PHYSIOL, 2012, 303 (7), pp. F1006-F1014
Abstract: Dysregulation of renal tubular protein handling in proteinuria contributes to the development of chronic kidney disease. We investigated the role of CD36 as a novel candidate mediator of albumin binding and endocytosis in the kidney proximal tubule using both in vitro and in vivo approaches, and in nephrotic patient renal biopsy samples. In CD36-transfected opossum kidney proximal tubular cells, both binding and uptake of albumin were substantially enhanced. A specific CD36 inhibitor abrogated this effect, but receptor-associated protein, which blocks megalin-mediated endocytosis of albumin, did not. Mouse proximal tubular cells expressed CD36 and this was absent in CD36 null animals, whereas expression of megalin was equal in these animals. Compared with wild-type mice, CD36 null mice demonstrated a significantly increased urinary protein-to-creatinine ratio and albumin-to-creatinine ratio. Proximal tubular cells expressed increased CD36 when exposed to elevated albumin concentrations in culture medium. Expression of CD36 was studied in renal biopsy tissue obtained from adult patients with heavy proteinuria due to minimal change disease, membranous nephropathy, or focal segmental glomerulosclerosis. Proximal tubular CD36 expression was markedly increased in proteinuric individuals. We conclude that CD36 is a novel mediator influencing binding and uptake of albumin in the proximal tubule that is upregulated in proteinuric renal diseases. CD36 may represent a potential therapeutic target in proteinuric nephropathy.
DOI Link: 10.1152/ajprenal.00021.2012
eISSN: 1522-1466
Links: http://hdl.handle.net/2381/27021
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:

There are no files associated with this item.

View Statistics

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.

 

MAINTAINER